These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32042661)

  • 21. The effect of treatment with pimobendan in dogs with preclinical mitral valve disease - a placebo-controlled double-blinded crossover study.
    Klein S; Nolte I; Rumstedt K; Sehn M; Raue JF; Weiner F; Treese JS; Beyerbach M; Bach JP
    BMC Vet Res; 2021 Sep; 17(1):310. PubMed ID: 34563187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suspected sequential left atrial ruptures in a dog with myxomatous mitral valve disease.
    Romito G; Testa F; Cipone M
    J Vet Cardiol; 2022 Dec; 44():18-22. PubMed ID: 36252456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Left Atrial Deformation and Function by 2-Dimensional Speckle Tracking Echocardiography in Healthy Dogs and Dogs With Myxomatous Mitral Valve Disease.
    Baron Toaldo M; Romito G; Guglielmini C; Diana A; Pelle NG; Contiero B; Cipone M
    J Vet Intern Med; 2017 May; 31(3):641-649. PubMed ID: 28455877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary intervention reduces left atrial enlargement in dogs with early preclinical myxomatous mitral valve disease: a blinded randomized controlled study in 36 dogs.
    Li Q; Heaney A; Langenfeld-McCoy N; Boler BV; Laflamme DP
    BMC Vet Res; 2019 Nov; 15(1):425. PubMed ID: 31775756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No impact of polymorphism in the phosphodiesterase 5A gene in Cavalier King Charles Spaniels on pimobendan-induced inhibition of platelet aggregation response.
    Reimann MJ; Faisst DN; Knold M; Meurs KM; Stern JA; Cremer SE; Møller JE; Ljungvall I; Häggström J; Olsen LH
    J Vet Intern Med; 2023; 37(6):2145-2156. PubMed ID: 37743723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of pimobendan for mitral valve regurgitation in dogs.
    Kanno N; Kuse H; Kawasaki M; Hara A; Kano R; Sasaki Y
    J Vet Med Sci; 2007 Apr; 69(4):373-7. PubMed ID: 17485924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a focused echocardiographic training program in first opinion practice.
    Dickson D; Harris J; Chang CH; Patteson M; Hezzell MJ
    J Vet Intern Med; 2022 Nov; 36(6):1913-1920. PubMed ID: 36221315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Echocardiographic predictors of first onset of atrial fibrillation in dogs with myxomatous mitral valve disease.
    Baron Toaldo M; Mazzoldi C; Romito G; Poser H; Contiero B; Cipone M; Guglielmini C
    J Vet Intern Med; 2020 Sep; 34(5):1787-1793. PubMed ID: 32767718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of intravenous administration of pimobendan on hemodynamic indices and indices of left atrial longitudinal strain derived from speckle-tracking echocardiography in healthy dogs.
    Miki S; Nakamura K; Morita T; Osuga T; Kawamoto S; Sasaki N; Takiguchi M
    Am J Vet Res; 2021 Oct; 82(10):795-801. PubMed ID: 34554874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left atrial ejection fraction assessed by real-time 3-dimensional echocardiography in normal dogs and dogs with myxomatous mitral valve disease.
    Tidholm A; Höglund K; Häggström J; Bodegård-Westling A; Ljungvall I
    J Vet Intern Med; 2013; 27(4):884-9. PubMed ID: 23731204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of dogs with compensated myxomatous mitral valve disease with spironolactone-a pilot study.
    Hezzell MJ; Boswood A; López-Alvarez J; Lötter N; Elliott J
    J Vet Cardiol; 2017 Aug; 19(4):325-338. PubMed ID: 28734620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compounded pimobendan for canine chronic degenerative mitral valve disease and pulmonary hypertension.
    Helms SR; Fox S; Mixon W; Vail J
    Int J Pharm Compd; 2012; 16(1):34-41. PubMed ID: 23050309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Echocardiographic evaluation of regurgitant fraction in dogs with subclinical myxomatous mitral valve disease: Method comparison, effects of pimobendan, and reproducibility.
    Ellis-Reis RE; Visser LC; Hsue W; Sharpe AN; Kaplan JL
    J Vet Cardiol; 2023 Feb; 45():27-40. PubMed ID: 36630740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of radiographic vertebral heart score and vertebral left atrial size cutoffs based on echocardiographic left atrial size in dogs with myxomatous mitral valve disease.
    Baisan RA; Vulpe V
    Vet Radiol Ultrasound; 2024 Jan; 65(1):54-61. PubMed ID: 38148480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inotropic effects of a single intravenous recommended dose of pimobendan in healthy dogs.
    Hori Y; Taira H; Nakajima Y; Ishikawa Y; Yumoto Y; Maekawa Y; Oshiro A
    J Vet Med Sci; 2019 Jan; 81(1):22-25. PubMed ID: 30404952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of pimobendan versus benazepril in canine myxomatous valvular disease.
    Boswood A; McEwan JD; French A; Little C; Swift S; Smith S; Patteson M
    Vet Rec; 2003 Oct; 153(14):439-40. PubMed ID: 14582738
    [No Abstract]   [Full Text] [Related]  

  • 37. Two radiographic methods for assessing left atrial enlargement and cardiac remodeling in dogs with myxomatous mitral valve disease.
    Vezzosi T; Puccinelli C; Citi S; Tognetti R
    J Vet Cardiol; 2021 Apr; 34():55-63. PubMed ID: 33581663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
    Cremer SE; Singletary GE; Olsen LH; Wallace K; Häggström J; Ljungvall I; Höglund K; Reynolds CA; Pizzinat N; Oyama MA
    J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs.
    Lombard CW; Jöns O; Bussadori CM
    J Am Anim Hosp Assoc; 2006; 42(4):249-61. PubMed ID: 16822763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial.
    Wess G; Kresken JG; Wendt R; Gaugele J; Killich M; Keller L; Simak J; Holler P; Bauer A; Küchenhof H; Glaus T
    J Vet Intern Med; 2020 Nov; 34(6):2232-2241. PubMed ID: 32945575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.